non-hemolytic transfusion reaction

non-hemolytic transfusion reaction

Transfusion medicine Immune reactivity to homologous WBCs in a previously sensitized blood product recipient, which occurs in 0.5–5.0% of all transfusions, and in up to 50% of Pts with βº thalassemia Prevention NTRs are minimized by using leukocyte-depleted blood products. See Leukocyte reduction.
References in periodicals archive ?
First of all, for preventing TT- CMV, based on the data of this study, but also for preventing febrile non-hemolytic transfusion reactions in multi-transfused patient populations (major beta thalassemia patients).
Full browser ?